Digital & Innovation
Cybersecurity tops investment priorities for ANZ companies
Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% prioritising it for 2025. Following closely are data analytics at 84%, cloud platforms at 83%, and generative AI (GenAI) at 81%.
Brian Ferreira, VP of EXP Advisory Services at Gartner, explained “With greater government regulation, coupled with some of the largest cyberattacks we’ve seen in ANZ this year, organisations face greater scrutiny as they batten down the hatches to avoid becoming the next target or breaching stewardship.
“This continues to drive significant focus and investment towards cybersecurity and legal compliance into next year.”
The 2025 Gartner Survey, which included insights from 3,186 respondents – 109 of whom were from ANZ across public, private, and non-profit sectors – revealed a significant shift in technology investment priorities.
Ferreira added, “GenAI has shot towards the top of the technology investment list for next year as organisations continue to navigate their way towards realising the business value that GenAI can offer as the hype subsides. They’re also facing more stringent laws to increase stewardship obligations.”
The survey also highlighted a notable shift in priorities, with 94% of ANZ companies now viewing improved operating margins as the most crucial outcome from digital technology investments, a dramatic rise from 48% in 2024.
Ensuring compliance and minimising risks follows closely at 92%, up from 57% last year, and excelling in customer experience stands at 87%, a significant increase from 70% in 2024.
Ferreira pointed out, “The uncertain economic climate businesses have operated in the last few years has increased executive and board scrutiny on technology investments.
“Next year will be critical for ANZ CIOs to prioritise technology activities, in conjunction with executive stakeholders, by aligning technology spend and resources to validated high-priority smart spending levers at the enterprise level.”
As regulatory landscapes in Australia and New Zealand continue to evolve, leaders are tasked with guiding their organisations towards a future defined by digital stewardship, responsible innovation, stringent compliance, and active engagement in shaping regulatory norms.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More